Gland Pharma Ltd Share Price

Overview

Gland Pharma Ltd share price is currently ₹2,766.87, down by - ₹10.88 (0.39%) from its previous closing price of ₹2,777.75. The share price has gained 17.44% over the past month and gained 42.44% over the past year. The stock's 52-week low and high are ₹1,548.75 and ₹3,001.03, respectively. Gland Pharma Ltd has a market capitalisation of ₹ 46,510.00 Cr. The share price was last updated on 24 Aug 2026, 03:29 PM IST.

Gland Pharma Ltd

GLAND

₹0.00

- ₹10.88

0.39%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:29:58 pm IST

Market Data

Open Price

₹2,764.92

Prev. Close

₹2,777.75

₹2,745.58

Day Low

₹2,771.79

Day High

₹1,548.75

52 Week Low

₹3,001.03

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

40.40

Sector PE

42.03

PB Ratio

4.42

Sector PB

5.82

EPS

68.49

Dividend Yield

1.18

Today's Volume

518.786 K

5 Day Avg. Volume

413.268 K

PEG Ratio

0.86

Market Cap.

₹ 46,510.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 2000% at ₹20/Share	11-Aug-2026	11-Aug-2026
DividendsFinal Dividend of 1800% at ₹18/Share	14-Aug-2025	14-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
HDFC Mid Cap Fund - Regular Plan - Growth	63.18 Lac	60.68 Lac (3.96%)
SBI Large & Midcap Fund - Regular Plan - IDCW	31.70 Lac	31.70 Lac no change
Nippon India Growth Mid Cap Fund - Growth Option	28.00 Lac	28.00 Lac no change
Mirae Asset Large & Midcap Fund - Regular Plan - Growth	28.50 Lac	24.55 Lac (13.85%)
ICICI Prudential India Opportunities Fund - Growth	24.58 Lac	24.03 Lac (2.24%)

Show all holdings

About Gland Pharma Ltd 👋

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.